October 21, 2021
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jordan Nimitz
Re: | Humacyte, Inc. |
Registration Statement Filed on Form S-1 (the “Registration Statement”) | |
File No. 333-259624 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Humacyte, Inc. (the “Company”) hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on October 25, 2021, or as soon as practicable thereafter.
Please contact Kerry S. Burke of Covington & Burling LLP at (202) 662-5297 or kburke@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Burke by telephone when this request for acceleration has been granted.
Respectfully, |
Humacyte, Inc. |
By: | /s/ Dale A. Sander |
Name: | Dale A. Sander |
Title: | Chief Financial Officer |
cc: Kerry S. Burke, Covington & Burling LLP
Brian K. Rosenzweig, Covington & Burling LLP
;_')MOPWE/_3U#_.O2*\S^.YQ\,YO^OJ'^9H C^ S
M[_A_.?\ J(2_^@I7J%>5_L_G/PZF/_41E_\ 04KU2@#P[]HA_+_X1P_]?/\
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M0%""71LY)/\ IT4 (5!&",BO'O%7P"TO5[V:]T2^.EO*2S6[1[X<_[(
M!!4>W(] *]BHH ^<4_9SUXR!9-;TU8\_>57)_+ _G7I/@?X/Z)X-NH]0>634
M=30';/*H5(\]T3G!]R2?I7HM% !7D4_P:NYOB2/%@UF$1_VBM]]G\@YP'#;=
MV[KQUQ7KM% !1110 5Y5X#^$=UX-\7R:W+J\5TCQ21^4L!4C<0>N3Z5ZK10!
MP/Q,\ :AX^AL+6#5HK&TMF:1T:$N7